Sandra Valencia

Dr. Sandra Valencia


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SVSandra Valencia
Sandra Valencia
Martha ZuluagaMartha Zuluaga
Martha Zuluaga
MPMaría Florian Pérez
María Florian Pérez
KMKevin Fernando Montoya-Quintero
Kevin Fernando Montoya-Quintero
Mariana S. Candamil-CortésMariana S. Candamil-Cortés
Mariana S. Candamil-Cortés
Sebastián RobledoSebastián Robledo
Sebastián Robledo
The gut microbiome plays a vital role in human health, functioning as a metabolic organ that influences nutrient absorption and overall well-being. With growing evidence that dietary interventions can modulate the microbiome and improve health, this review examines whether healthcare systems should prioritize personalized microbiome-targeted therapies, such as probiotics, prebiotics, and microbiota transplants, over traditional pharmaceutical treatments for chronic diseases like obesity, diabetes, cardiovascular risk, and inflammatory conditions. A systematic review using Web of Science and Scopus databases was conducted, followed by a scientometric analysis. Key metabolic pathways, such as dietary fiber fermentation and short-chain fatty acid production, were explored, focusing on their impact on lipid and glucose metabolism. The interactions between microbial metabolites and the immune system were also investigated. Dietary interventions, including increased fiber and probiotic intake, show potential for addressing dysbiosis linked to conditions, such as type 2 diabetes, obesity, and autoimmune diseases. The review emphasizes the need to incorporate microbiome modulation strategies into clinical practice and research, calling for a multidisciplinary approach that integrates nutrition, microbiology, and biochemistry to better understand the gut microbiome’s complex role in health.

25 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SVSandra Valencia
Sandra Valencia
Martha ZuluagaMartha Zuluaga
Martha Zuluaga
MPMaría Florian Pérez
María Florian Pérez
KMKevin Fernando Montoya-Quintero
Kevin Fernando Montoya-Quintero
Mariana S. Candamil-CortésMariana S. Candamil-Cortés
Mariana S. Candamil-Cortés
Sebastián RobledoSebastián Robledo
Sebastián Robledo
The gut microbiome plays a vital role in human health, functioning as a metabolic organ that influences nutrient absorption and overall well-being. With growing evidence that dietary interventions can modulate the microbiome and improve health, this article examines whether healthcare systems should prioritize personalized microbiome-targeted therapies, such as probiotics, prebiotics, and microbiota transplants, over traditional pharmaceutical treatments for chronic diseases like obesity, diabetes, cardiovascular risk, and inflammatory conditions. A systematic review using Web of Science and Scopus databases was conducted, followed by a scientometric analysis. Key metabolic pathways, such as dietary fiber fermentation and short-chain fatty acid production, were explored, focusing on their impact on lipid and glucose metabolism. The interactions between microbial metabolites and the immune system were also investigated. Dietary interventions, including increased fiber and probiotic intake, show potential for addressing dysbiosis linked to conditions like type 2 diabetes, obesity, and autoimmune diseases. The review emphasizes the need to incorporate microbiome modulation strategies into clinical practice and research, calling for a multidisciplinary approach that integrates nutrition, microbiology, and biochemistry to better understand the gut microbiome’s complex role in health.

25 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SVSandra Valencia
Sandra Valencia
Martha ZuluagaMartha Zuluaga
Martha Zuluaga
MBMaría Camila Bernal
María Camila Bernal
JHJuan Pablo Hernández-Ovalle
Juan Pablo Hernández-Ovalle
AUAna Lorena Uribe
Ana Lorena Uribe
Human breast milk is a dynamic biological fluid essential for infant growth, immune regulation, and early metabolic development. Maternal diabetes mellitus can alter its molecular composition, potentially impacting its nutritional value and the infant’s future metabolic health. This study compared the metabolomic profiles of breast milk from healthy versus diabetic women using untargeted metabolomics with GC/MS-QTOF on samples from normoglycemic and type 2 diabetic cohorts. Supervised multivariate statistics and metabolic pathway analysis identified discriminant metabolites and clarified biological relevance. Distinct metabolomic signatures were found: milk from diabetic mothers showed changes in short-chain fatty acids, amino acid derivatives, carbohydrates, and lipid-related molecules, with alterations in pathways such as energy metabolism, oxidative stress, and microbial co-metabolism. These specific changes in the milk metabolome may influence infant metabolic programming and highlight the need for personalized nutritional approaches for mothers with metabolic disorders, supporting metabolomics as a tool to monitor breast milk quality.